Enter at least 4 characters

1 results showing for: 'lenalidomide (viatris)'

- Special Authority SA2353 [PDF] -- Retail pharmacy
  • Cap 5 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673525
    • Subsidy $76.92
    • Measure / Qty per 21
    Lenalidomide Viatris to be Principal Supply on 1 February 2025
  • Cap 10 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673533
    • Subsidy $50.30
    • Measure / Qty per 21
    Lenalidomide Viatris to be Principal Supply on 1 February 2025
  • Cap 15 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673541
    • Subsidy $62.13
    • Measure / Qty per 21
    Lenalidomide Viatris to be Principal Supply on 1 February 2025
  • Cap 25 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673568
    • Subsidy $65.09
    • Measure / Qty per 21
    Lenalidomide Viatris to be Principal Supply on 1 February 2025
  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply